Your browser doesn't support javascript.
loading
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.
Fan, Rong; Sun, Jian; Yuan, Quan; Xie, Qing; Bai, Xuefan; Ning, Qin; Cheng, Jun; Yu, Yanyan; Niu, Junqi; Shi, Guangfeng; Wang, Hao; Tan, Deming; Wan, Mobin; Chen, Shijun; Xu, Min; Chen, Xinyue; Tang, Hong; Sheng, Jifang; Lu, Fengmin; Jia, Jidong; Zhuang, Hui; Xia, Ningshao; Hou, Jinlin.
Affiliation
  • Fan R; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Sun J; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yuan Q; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China.
  • Xie Q; Department of Infectious Diseases, Ruijin Hospital, Jiaotong University School of Medicine, Shanghai, China.
  • Bai X; Department of Infectious Diseases, Tangdu Hospital, Xi'an, China.
  • Ning Q; Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Cheng J; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Yu Y; Department of Infectious Diseases, First Hospital of Peking University, Beijing, China.
  • Niu J; Department of Hepatology, First Hospital, Jilin University, Changchun, China.
  • Shi G; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Wang H; Hepatology Unit, Peking University People's Hospital, Beijing, China.
  • Tan D; Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, China.
  • Wan M; Department of Infectious Diseases, Changhai Hospital, Shanghai, China.
  • Chen S; Ji'nan Infectious Diseases Hospital, Ji'nan, China.
  • Xu M; 8th People's Hospital, Guangzhou, China.
  • Chen X; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Tang H; Department of Infectious Diseases, West China Hospital, Chengdu, China.
  • Sheng J; Department of Infectious Diseases, Zhejiang University 1st Affiliated Hospital, Hangzhou, China.
  • Lu F; Department of Microbiology, Health science Center, Peking University, Beijing, China.
  • Jia J; Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Zhuang H; Department of Microbiology, Health science Center, Peking University, Beijing, China.
  • Xia N; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China.
  • Hou J; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China Collaborative Innovation Center for Diagnosis and Treatment of Infec
Gut ; 65(2): 313-20, 2016 Feb.
Article in En | MEDLINE | ID: mdl-25586058

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon-alpha / Hepatitis B, Chronic / Seroconversion / Hepatitis B Antibodies / Hepatitis B e Antigens / Nucleosides Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Gut Year: 2016 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon-alpha / Hepatitis B, Chronic / Seroconversion / Hepatitis B Antibodies / Hepatitis B e Antigens / Nucleosides Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Gut Year: 2016 Type: Article Affiliation country: China